Page last updated: 2024-10-31

methoxyamine and Pancreatic Neoplasms

methoxyamine has been researched along with Pancreatic Neoplasms in 1 studies

methoxyamine: analytical reagent for aldehydes and ketones; strong irritant, can probably produce methemoglobinemia; RN given refers to parent cpd; structure

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakrabarti, G1
Silvers, MA1
Ilcheva, M1
Liu, Y1
Moore, ZR1
Luo, X1
Gao, J1
Anderson, G1
Liu, L1
Sarode, V1
Gerber, DE1
Burma, S1
DeBerardinis, RJ1
Gerson, SL1
Boothman, DA1

Other Studies

1 other study available for methoxyamine and Pancreatic Neoplasms

ArticleYear
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.
    Scientific reports, 2015, Nov-25, Volume: 5

    Topics: Animals; Autophagy; Catalase; Cell Line, Tumor; Cell Survival; Dicumarol; DNA Breaks, Double-Strande

2015